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ABSTRACT 
Aim: This review article is an attempt to analyse the probable mode of action of Kalyanaka ghrita in 
psychiatric conditions. Background: Unmada is a term that represents broad classes of mental 
ailments in Ayurvedic literature. Mental disorders impose an enormous burden on society, 
accounting for almost one in three years lived with disability globally. According to the WHO, every 
year, almost one million people die from suicide; a "global" mortality rate of 16 per 1,00,000 or one 
death every 40 seconds. Kalyanaka ghrita is a time tested and clinically proven polyherbal 
formulation which is widely and effectively used by Ayurvedic physicians in the management of 
psychiatric conditions. Results: While analysing the Rasapanchaka (Ayurvedic Principles of Drug-
Action), it is found that of the 28 ingredients, 15 drugs are having Tikta rasa, 22 with Laghu guna, 
19 with Ushna veerya and 18 with Katu vipaka. Considering Doshaharatwa, 12 drugs are 
Kaphapittahara. All these properties are against Kapha dosha. Conclusion: Kalyanaka ghrita may 
be more effective in the management of Kaphaja unmada, among all the 6 varieties of Unmada. 
Clinical Significance: Analysis of mode of action leads us to the inference that Kalyanaka ghrita 
may be more effective in the management of Kaphaja unmada, characterized by slow or weak voice 
and body movements, anorexia, desire for women (sex) and solitude, excessive sleep, vomiting, 
dribbling of saliva, symptoms pronounced just after intake of food, whitish discoloration of nails 
constitute Kaphaja unmada, a classical example being depression. 
KEYWORDS: Mode of action, Kalyanaka Ghrita, Unmada, Insanity, Others. 
INTRODUCTION 
Unmada is a term that represents broad 
classes of mental ailments in Ayurvedic literature. 
Unmada is explained in Ayurveda as the 
derangement in Manas (mental functioning), Budhi 
(application of the acquired knowledge), Samjna 
(perceptions), Jnana (experiences), Smriti (memory), 
Bhakti (emotional adhesions), Seela (conditioned 
activities), Cheshta (behavior) and Achara (socio 
cultural activities)1.  
Mental disorders impose an enormous 
burden on society, accounting for almost one in three 
years lived with disability globally. 80% of the people 
likely to experience an episode of a mental disorder 
in their lifetime. Two of the most common forms of 
mental disorders are anxiety and depression 2. Nearly 
80% of people with mental disorders live in low- and 
middle-income countries, which account for more 
than 10% of total burden of disease in these 
countries 3. Among the several causes of YLD (years 
lived with disability), depression is leading as the 
second cause. Anxiety disorders, schizophrenia, 
bipolar disorders, prescription drug overuse, 
headache, other substances abuse, Alzheimer’s 
disease, alcohol use disorders, and epilepsy are 
global neuropsychiatric causes of YLD. 4 
 It is obvious that psychiatric illnesses are 
often disabling, and this is reflected in the markedly 
higher proportion of overall disease burden caused 
by the mental illnesses. It is of importance to note, 
untreated mental illnesses also cause mortality due 
to suicide. Worldwide, suicide is a major cause for 
concern. According to the WHO, every year, almost 
one million people die from suicide; a "global" 
mortality rate of 16 per 1,00,000 or one death every 
40 seconds. In the last 45 years, suicide rates have 
increased by 60% worldwide. Suicide is among the 
three leading causes of death among those aged 15-
44 years in some countries, and the second leading 
cause of death in the 10–24 years age group. These 
figures do not include suicide attempts which are up 
to 20 times more frequent than completed suicide. 
Suicide worldwide is estimated to represent 1.8% of 
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the total global burden of disease in 1998 and 
projected to reach 2.4% of total burden of disease in 
countries with market and former socialist 
economies in 2020.5 
Kalyanaka ghrita is a time tested and 
clinically proven6 polyherbal formulation which is 
widely and effectively used by Ayurvedic physicians 
in the management of a wide array of disorders. It is 
found to be beneficial in personality disorders, curing 
insanity, cough, epilepsy, anaemia, itching, poison, 
consumption, delusion, Diabetes mellitus, artificial 
poison, fever, scanty semen volume, infertility, those 
having poor intelligentia, stammering speech, who 
desire good memory, who have poor digestive power. 
It bestows strength, auspiciousness, long life, 
complexion, fortune and nourishment. However, it is 
more widely used in the management of psychiatric 
conditions. This review article is an attempt to 
analyse the probable mode of action of Kalyanaka 
ghrita in psychiatric conditions. 
Materials and methods 
Data was collected by thorough literature 
review of Samhitas (classical texts), Nighantus 
(lexicons) and published research articles.  
Aetiopathogenesis of Unmada: Unmada is a term 
that represents broad classes of mental ailments in 
Ayurvedic literature.  
Doshas which have undergone increase and 
traversing upwards through the channels of mind 
(Manovaha srotas) get localized in the mind and 
cause its abnormality. This disease is called Unmada, 
it is mainly a disease of the mind.  
Varieties: There are six varieties. One from each 
Dosha (Vataja, Pittaja, Kaphaja), fourth from a 
combination of all the three (Sannipataja), fifth from 
grief etc (Aadhija), sixth from poisons (Vishaja). 
Cause: Indulgence in foods which are incompatible, 
spoilt and unclean, showing disrespect to gods, 
preceptors (elders) or Brahmins, emotions affecting 
the mind like fear, joy etc and violent physical 
activities 
Pathogenesis: In persons who are mentally weak, 
doshas which have undergone increase invade 
hridaya (seat of mind), get lodged in channels of the 
mind and bring about the derangement of mind 
quickly. 
General symptoms: Improper understanding, 
unsteadiness of mind, non coordination of sight, 
feeling of fear, irrelevant talk, feeling of emptiness of 
heart 
Symptoms of Vataja unmada: Laughing, smiling, 
dancing, singing, speaking, making movement of 
body parts and weeping at improper time and place, 
hardness/ roughness, emaciation, blackish red 
discoloration of the body, exacerbation of symptoms 
after digestion of food 
Symptoms of Pittaja unmada: Intolerance, 
uncontrollability, casting away the clothes and 
remaining naked, threatening others, running away, 
feeling of burning sensation, desiring shades, cool 
water and food, yellowish discoloration of the body 
Symptoms of Kaphaja unmada: Slow or weak voice 
and body movements, anorexia, desire for women 
(sex) and solitude, excessive sleep, vomiting, 
dribbling of saliva, symptoms pronounced just after 
intake of food, whitish discoloration of nails. 
Symptoms of Sannipataja unmada: There will be 
symptoms produced due to each Dosha. Its treatment 
is very difficult. 
Symptoms of Adhija unmada: Person talks 
indifferently, reveals secret, sings, laughs or weeps 
on his own accord and behave senselessly. 
Symptoms of Vishaja unmada: Patient will have red 
eyes, loss of strength of body, sense and complexion, 
helplessness, black discoloration of the face or mouth 
and loss of consciousness.7 
Mental disorders: Key facts8 
 There are many different mental disorders, with 
different presentations. They are generally 
characterized by a combination of abnormal 
thoughts, perceptions, emotions, behaviour and 
relationships with others. 
 Mental disorders include: depression, bipolar 
affective disorder, schizophrenia and other 
psychoses, dementia, intellectual disabilities and 
developmental disorders including autism. 
 There are effective strategies for preventing 
mental disorders such as depression. 
 There are effective treatments for mental 
disorders and ways to alleviate the suffering 
caused by them. 
 Access to health care and social services capable of 
providing treatment and social support is key. 
The burden of mental disorders continues to 
grow with significant impacts on health and major 
social, human rights and economic consequences in 
all countries of the world. Let us analyse them. 
Depression 
Depression is a common mental disorder and 
one of the main causes of disability worldwide. 
Globally, an estimated 300 million people are affected 
by depression. More women are affected than men. 
Depression is characterized by sadness, loss 
of interest or pleasure, feelings of guilt or low self-
worth, disturbed sleep or appetite, tiredness, and 
poor concentration. People with depression may also 
have multiple physical complaints with no apparent 
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physical cause. Depression can be long-lasting or 
recurrent, substantially impairing people’s ability to 
function at work or school and to cope with daily life. 
At its most severe, depression can lead to suicide. 
Prevention programmes have been shown to 
reduce depression, both for children (e.g. through 
protection and psychological support following 
physical and sexual abuse) and adults (e.g. through 
psychosocial assistance after disasters and conflicts). 
There are also effective treatments. Mild to 
moderate depression can be effectively treated with 
talking therapies, such as cognitive behaviour 
therapy or psychotherapy. Antidepressants can be an 
effective form of treatment for moderate to severe 
depression but are not the first line of treatment for 
cases of mild depression. They should not be used for 
treating depression in children and are not the first 
line of treatment in adolescents, among whom they 
should be used with caution. 
Management of depression should include 
psychosocial aspects, including identifying stress 
factors, such as financial problems, difficulties at 
work or physical or mental abuse, and sources of 
support, such as family members and friends. The 
maintenance or reactivation of social networks and 
social activities is important. 
Bipolar affective disorder 
This disorder affects about 60 million people 
worldwide. It typically consists of both manic and 
depressive episodes separated by periods of normal 
mood. Manic episodes involve elevated or irritable 
mood, over-activity, pressure of speech, inflated self-
esteem and a decreased need for sleep. People who 
have manic attacks but do not experience depressive 
episodes are also classified as having bipolar 
disorder. 
Effective treatments are available for the 
treatment of the acute phase of bipolar disorder and 
the prevention of relapse. These are medicines that 
stabilize mood. Psychosocial support is an important 
component of treatment. 
Schizophrenia and other psychoses 
Schizophrenia is a severe mental disorder, 
affecting about 23 million people worldwide. 
Psychoses, including schizophrenia, are characterized 
by distortions in thinking, perception, emotions, 
language, sense of self and behaviour. Common 
psychotic experiences include hallucinations 
(hearing, seeing or feeling things that are not there) 
and delusions (fixed false beliefs or suspicions that 
are firmly held even when there is evidence to the 
contrary). The disorder can make it difficult for 
people affected to work or study normally. 
Stigma and discrimination can result in a lack 
of access to health and social services. Furthermore, 
people with psychosis are at high risk of exposure to 
human rights violations, such as long-term 
confinement in institutions. 
Schizophrenia typically begins in late 
adolescence or early adulthood. Treatment with 
medicines and psychosocial support is effective. With 
appropriate treatment and social support, affected 
people can lead a productive life, be integrated in 
society. Facilitation of assisted living, supported 
housing and supported employment can act as a base 
from which people with severe mental disorders, 
including Schizophrenia, can achieve numerous 
recovery goals as they often face difficulty in 
obtaining or retaining normal employment or 
housing opportunities. 
Dementia 
Worldwide, approximately 50 million people 
have dementia. Dementia is usually of a chronic or 
progressive nature in which there is deterioration in 
cognitive function (i.e. the ability to process thought) 
beyond what might be expected from normal ageing. 
It affects memory, thinking, orientation, 
comprehension, calculation, learning capacity, 
language, and judgment. The impairment in cognitive 
function is commonly accompanied, and occasionally 
preceded, by deterioration in emotional control, 
social behaviour, or motivation. 
Dementia is caused by a variety of diseases 
and injuries that affect the brain, such as Alzheimer's 
disease or stroke. 
Though there is no treatment currently 
available to cure dementia or to alter its progressive 
course, many treatments are in various stages of 
clinical trials. Much can be done, however, to support 
and improve the lives of people with dementia and 
their carers and families. 
Developmental disorders, including autism 
Developmental disorder is an umbrella term 
covering intellectual disability and pervasive 
developmental disorders including autism. 
Developmental disorders usually have a childhood 
onset but tend to persist into adulthood, causing 
impairment or delay in functions related to the 
central nervous system maturation. They generally 
follow a steady course rather than the periods of 
remissions and relapses that characterize many other 
mental disorders. 
Intellectual disability is characterized by 
impairment of skills across multiple developmental 
areas such as cognitive functioning and adaptive 
behaviour. Lower intelligence diminishes the ability 
to adapt to the daily demands of life. 
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Symptoms of pervasive developmental 
disorders, such as autism, include impaired social 
behaviour, communication and language, and a 
narrow range of interests and activities that are both 
unique to the individual and are carried out 
repetitively. Developmental disorders often originate 
in infancy or early childhood. People with these 
disorders occasionally display some degree of 
intellectual disability. 
Family involvement in care of people with 
developmental disorders is very important. Knowing 
what causes affected people both distress and 
wellbeing is an important element of care, as is 
finding out what environments are most conductive 
to better learning. Structure to daily routines help 
prevent unnecessary stress, with regular times for 
eating, playing, learning, being with others, and 
sleeping. Regular follow up by health services of both 
children and adults with developmental disorders is 
needed. The community at large has a role to play in 
respecting the rights and needs of people with 
disabilities. 
Kalyanaka ghrita9  
 Let us analyse the ingredients and indications 
of Kalyanaka ghrita, which is a widely used classical 
formulation to treat Unmada.  
Ingredients of Preparation: Medicated ghee is 
prepared with the decoction and paste of each of 
Vara (Terminalia chebula Retz., Emblica officinalis 
Gaertn., Terminalia bellirica (Gaertn.) Roxb.), Vishala 
(Citrullus colocynthis (L.) Schrad), Bhadraila 
(Amomum subulatum Roxb.), Devadaru (Cedrus 
deodara (Roxb. ex D.Don) G.Don), Elavaluka (Prunus 
cerasus Linn.), two Sariva (Hemidesmus indicus (L.) 
R.Br.exSchult. and Cryptolepis dubia (Burm.f.) M.R. 
Almeida), two Rajani (Curcuma longa L and 
Coscinium fenestratum (Goetgh.) Colebr.), two Sthira 
[Uraria picta (Jacq.) DC and Pseudarthria viscida (L.) 
Wight & Arn.], Phalini (Callicarpa macrophylla Vahl), 
Nata (Valeriana wallichii DC), Brihati (Solanum 
indicum L), Kushtha (Saussurea costus (Falc.) Lipsch.), 
Manjishtha (Rubia cordifolia L.), Nagakesara (Mesua 
ferrea L.), Dadima (Punica granatum L.), Vella 
(Embelia ribes Burm.f.), Talisapatra (Abies 
spectabilis (D.Don) Mirb.), Ela (Elettaria 
cardamomum (L.) Maton), Malatimukula (Jasminum 
sambac (L.) Aiton), Utpala (Nymphaea nouchali 
Burm.f.), Danti (Baliospermum solanifolium (Burm.) 
Suresh), Padmaka (Prunus cerasoides Buch.-Ham. ex 
D.Don), Hima (Santalum album L) and ghee.  
Indications 
It is said to be beneficial in personality 
disorders, curing insanity, cough, epilepsy, diseases 
caused by sinful deeds, anaemia, itching, poison, 
consumption, delusion, Diabetes mellitus, artificial 
poison, fever, scanty semen volume, infertility, in 
whom the mind is affected by gods, those having poor 
intelligentia, stammering speech, who desire good 
memory, who have poor digestive power. It bestows 
strength, auspiciousness, long life, complexion, 
fortune and nourishment. This is best for Pumsavana 
(treatment modality to get male progeny). 
Analysis of Rasapanchaka of Kalyanaka ghrita 
(Table1): 
Table 1. Pharmacological properties of herbal ingredients 
S. No. Drug (Sanskrit 
name) 
Rasa Guna Virya Vipaka Karma 
1 Haritaki10 Madhura, Amla, 
Katu, Tikta, 
Kashaya 
Laghu, Ruksha 
Sara 
Ushna Madhura Deepani, Medhya, 
Rasayana, Brimhani, 
Anulomani, 
Tridoshahara 
2 Amalaki11 Madhura, Amla, 
Katu, Tikta, 
Kashaya 
Laghu, Ruksha 
Sara 
Sheeta Madhura Rasayana 
Tridoshahara 
3 Vibhitaki12 Kashaya Laghu Ruksha, 
Sara 
Ushna Madhura Kaphapittahara 
4 Vishala 13 Tikta Laghu Sara Ushna Katu Pitta kapha hara 
5 Bhadraila 14 Katu Laghu Ushna Ushna Katu Deepana 
Kapha pitta hara 
6 Devadaru 15 Tikta Laghu Snigdha Ushna Katu Kapha pitta hara 
7 Elavaluka 16 Kashaya Laghu Seetha katu Kapha pitta hara 
8 Sariba 17 Madhura  Snigdha guru Seetha Madhura Deepana, 
Tridoshahara 
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9 Krishna Sariba Madhura  Snigdha guru Seetha Madhura Deepana, 
Tridoshahara 
10 Haridra 18 Katu tikta Laghu Ruksha Ushna Katu Kapha pitta hara 
11 Daruharidra19 Katu tikta Laghu Ruksha Ushna Katu Kapha pitta hara 
12 Prishniparni20 Madhura Laghu Sara Ushna Madhura Tridoshahara 
13 Shalaparni 21 Tikta Madhura Guru Ushna Madhura Tridoshahara, 
Rasayana, Brimhana 
14 Priyangu 22 Tikta kashaya Guru Ruksha Seetha Katu Vatapittahara, 
Bhranti, Moha 
15 Nata 23 Madhura Laghu Snigdha Ushna Katu Tridoshahara 
16 Brihati24 Katu tikta Laghu Ushna Katu Kapha vatahara 
17 Kushta 25 Katu madhura 
tikta 
Laghu Ushna Katu Vatakaphahara 
18 Manjishta 26 Madhura tikta 
kashaya 
guru Ushna Katu Kapharaktahara 
19 Nagakesara27 Kashaya Laghu ruksha Ushna Katu Kaphapitta hara 
20 Dadima 28 Madhura kashaya Laghu snigdha Ushna Amla Tridoshahara, 
Tarpana, Medhavaham 
21 Vella 29 Katu Teekshna 
ruksha laghu 
Ushna Katu Deepana, Kapha vata 
hara 
22 Talisapatra 30 Tikta madhura Laghu 
teekshna 
Ushna Katu Kapha vata hara, 
Deepana 
23 Ela 31 Katu laghu Seetha Madhura Vata hara 
24 Malatimukula32 Tikta kashaya laghu Ushna Katu Anila rakta hara 
25 Utpala33 Madhura Guru ruksha Seetha Madhura Kaphapittahara 
26 Danti34 Katu Laghu Sara 
teekshna 
Ushna Katu Deepan, 
Pittakaphahara 
27 Padmaka 35 Kashaya tikta laghu Seetha Katu Kapha pitta hara 
28 Hima 36 Tikta Ruksha laghu Seetha Katu Kapha pitta hara 
Rasa (taste): 15 drugs are having Tikta rasa (bitter taste), 12 having Madhura rasa (sweet taste), 10 each 
with Katu (pungent) and Kashaya rasa (astringent tastes) and 2 with Amla rasa (sour tastes) [Graph.1] 
Fig 1: Distribution of six Rasa (tastes) in ingredients of Kalyanaka ghrita 
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Guna (property): 22 drugs are Laghu (easy to digest) and 8 are Guru (difficult to digest) [Graph.2]. 
Fig 2: Distribution of Laghu (easy to digest) and guru Guna (difficult to digest properties) in ingredients of 
Kalyanaka ghrita 
 
Veerya (potency): 19 drugs are having Ushna veerya (hot potency) and 9 drugs are having Seetha veerya (cold 
potency) [Graph.3] 
Fig 3: Distribution of Ushna (hot) and Seetha veerya (cold potencies) in ingredients of Kalyanaka ghrita 
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Fig 4: Distribution of Madhura (sweet), Amla (sour) and Katu (pungent) Vipaka in ingredients of Kalyanaka 
ghrita 
 
Karma: 12 drugs are Kaphapittahara (alleviating 
Kapha and Pitta), 8 drugs are Tridoshahara 
(alleviating Vata, Kapha and Pitta), 4 drugs are 
Kaphavatahara (alleviating Kapha and Vata), 1 each 
are Kapharaktahara (alleviating Kapha and Rakta), 
Vatahara (alleviating Vata), Vataraktahara 
(alleviating Vata and Rakta), Vatapittahara 
(alleviating Vata and Pitta). 
Apart from this, Haritaki is Deepani 
(improves appetite), Medhya (promoting intellect), 
Rasayana (increases quality of Dhatus) and Brimhani 
(nourishing). Amalaki is Rasayana, Shalaparni is 
Rasayana and Brimhana, Sariba, Krishna Sariba and 
Bhadraila is Deepana, Dadima is Brimhani and 
Medhya. Priyangu is the only drug said to be indicated 
in Bhranti (Insanity), Moha (delusion) in this 
formulation.  
Research 
Anti oxidant property has been scientifically 
proven in most of the drugs (20 out of 28 
ingredients), via. Emblica officinalis37, Terminalia 
belerica38,Citrullus colocynthis (L.) Schrad.39, Amomum 
subulatum Roxb40, Cedrus deodara (Roxb. ex D.Don) 
G.Don41, Prunus cerasus Linn42, Hemidesmus indicus 
(L.)R.Br.ex Schult43, Cryptolepis dubia (Burm.f.) 
M.R.Almeida44, Curcuma longa L45, Coscinium 
fenestratum (Goetgh.) Colebr.)46, Pseudarthria 
viscid47, Callicarpa macrophylla48, Valeriana 
wallichii 49, Saussurea lappa50, Rubia cordifolia51, 
Punica granatum52, Elettaria cardamomum53, 
Jasminum sambac54, Nymphaea nouchali55, Santalum 
album.56  
 Apart from this, many drugs are scientifically 
proved in insanity or conditions of the brain which 
are very close to it like, Terminalia chebula in 
Alzheimer’s disease57, Emblica officinalis in insanity58, 
Cedrus deodara (Roxb. ex D.Don) G.Don as anxiolytic, 
neuroleptic and anticonvulsant41, (Prunus cerasus L.) 
modulate cerebral blood flow59, Curcuma longa L in 
major depression45, Pseudarthria viscida as 
neuroprotective60, Valeriana wallichii as anti 
depressant61, improves sleep62 and neuro-
protective63, Rubia cordifolia as having anti stress and 
nootropic action64, Punica granatum as 
Antidepressant and having Anti-Anxiety Effect65, 
Embelia ribes having antidepressant-like activity66, 
Elettaria cardamomum having Antidepressant and 
Anti-Anxiety Effect53,67, Jasminum sambac having anti 
stress effect68 and Santalum album is sedative and 
neuro protective.56,69 
Discussion and results 
Unmada is a broad term that represents 
broad classes of mental ailments in Ayurvedic 
literature. There are many different mental disorders, 
with different presentations. They are generally 
characterized by a combination of abnormal 
thoughts, perceptions, emotions, behaviour and 
relationships with others. Mental disorders impose 
an enormous burden on society, accounting for 
almost one in three years lived with disability 
globally. 80% of the people likely to experience an 
episode of a mental disorder in their lifetime. It is of 
importance to note, untreated mental illnesses also 
cause mortality due to suicide. Worldwide, suicide is 
a major cause for concern. According to the WHO, 
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every year, almost one million people die from 
suicide; a "global" mortality rate of 16 per 1,00,000 
or one death every 40 seconds.  
Kalyanaka ghrita is a widely used polyherbal 
formulation used in the management of mental 
disorders in Ayurveda. This review article is an 
attempt to analyse the probable mode of action of 
Kalyanaka ghrita in psychiatric conditions. While 
analysing the Rasapanchaka (Ayurvedic Principles of 
Drug-Action), it is found that of the 28 ingredients, 15 
drugs are having Tikta rasa, 22 with Laghu guna, 19 
with Ushna veerya and 18 with Katu vipaka. 
Considering Doshaharatwa, 12 drugs are Kapha-
pittahara. All these properties are against Kapha 
dosha. So, Kalyanaka ghrita may be more effective in 
the management of Kaphaja unmada. Psychological 
diseases characterised by slow or weak voice and 
body movements, anorexia, desire for women (sex) 
and solitude, excessive sleep, vomiting, dribbling of 
saliva, symptoms pronounced just after intake of 
food, whitish discoloration of nails constitute 
Kaphaja unmada, a classical example being 
depression. 
Haritaki, Sarivadaya, Ela, have Deepana, and 
Amadoshanashak properties so that it regulates 
Jatharagni, Dhatvagni and Bhutagni which corrects 
metabolism at cellular level, results in proper 
formation of Dhatus and Upadhatus and 
Strotoshodhan by removing Ama. Haritaki, Amalaki, 
Vibhitaki, Visala, Danti has Sara Guna and Virechak 
action so that they regulate Doshas by Samshodhana 
karma. Thus Samshodhana karma clears the Strotas 
and regulates function of Tridosha. 
 Antioxidant supplement therapy as an 
adjuvant therapy is useful in patients with stress-
induced psychiatric disorders.70 It is well 
documented that antioxidants can remove the 
reactive oxygen species (ROS) and reactive nitrogen 
species (RNS) through scavenging radicals and 
suppressing the OS pathway, which further protect 
against neuronal damage caused oxidative or 
nitrosative stress sources in the brain, hopefully 
resulting in remission of depression or anxiety 
symptoms71. Thus the anti oxidant property of most 
of the ingredients also will be contributing to the 
action of the formulation in psychiatric illnesses.  
 Role of Ghrita 
Among all the Snigdha (unctuous) substances, 
Ghrita is considered as best in Ayurveda72. It is one of 
the Nitya Rasayanas (can be consumed daily) 
mentioned in Ayurveda.73 It is sweet in taste, provide 
unctuousness and softness to the body tissues and 
cold in potency. The properties of Ghrita are to 
alleviate Vata and Pitta without increasing Kapha 
much. It improves the digestive fire, improves 
eyesight, intelligence, memory, vitalizes the body and 
gives luster. It improves semen and Ojus- the ultimate 
product of metabolism of food. Ghrita is known best 
for treating poisoning, insanity, seizures, pain, fever. 
It is said to provide auspiciousness and protection74. 
The most peculiar property of Ghrita is that it 
imbibes the property of the drug added to it 
providing a synergetic action in combination.75  
The most important cause of Unmada is 
described as Heena satwa (timid personality) of an 
individual. They will be mentally weak. Their Ojas 
will be affected. This depletion can be compensated 
by Ghrita. Inauspicious things like disrespecting 
elders are one cause of Unmada. Ghrita has the 
property of destroying inauspiciousness and giving 
protection. Vata dosha is the controller of the mind76 
and Medha is the property of Pitta77. So normalcy of 
Pitta and Vata are major concerns in the treatment of 
psychiatric illness like Unmada which can be done by 
the Vatapitta hara property of Ghrita.  
The influential factors of drug distribution in 
blood are mainly difference in blood flow, lipid 
solubility and ionization. An aqueous soluble drug is 
usually absorbed in extra cellular spaces. They do not 
diffuse to CSF and other body cavities, whereas lipid 
soluble drugs are readily available to extra and intra 
cellular spaces. Blood brain barrier (BBB) has a 
lipophilic molecular structure. This makes the lipids 
and lipid soluble drugs pass easily through BBB. So 
the drugs which are given in the form of ghee which 
are lipids rapidly absorbed in the target areas of 
central nervous system. Traditionally prepared ghee 
contains DHA, an omega 3 long chain poly 
unsaturated fatty acid. This is seen in high 
concentration in brain cells too. Moreover studies 
have shown that DHA have positive outcome in 
cognitive decline. Ghee is known to have antioxidant 
property which acts upon the degenerative brain 
cells and repair them. It also acts in normalizing the 
chemical changes in brain by balancing the 
neurotransmitters. By applying the theory of 
similarity, it can be said Mastishka (brain) which 
resembles molten ghee can be supplemented with 
clarified butter in various therapies78. 
Conclusion 
 Analysis of mode of action leads us to the 
inference that Kalyanaka ghrita may be more 
effective in the management of Kaphaja unmada, 
characterised by slow or weak voice and body 
movements, anorexia, desire for women (sex) and 
solitude, excessive sleep, vomiting, dribbling of saliva, 
symptoms pronounced just after intake of food, 
whitish discoloration of nails constitute Kaphaja 
unmada, a classical example being depression. 
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